APH vs DVA · P/E 40, rev $23.09B vs P/E 14, rev $12.82B
Amphenol Corporation (APH) versus DaVita HealthCare Partners Inc (DVA) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
APH currently screens at market cap $170.77B and trailing P/E 39.9. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Not investment advice. Open the APH and DVA stock pages for the full models.
Not investment advice.